TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan TAMU Executive Education Program on Health, Pharmaceuticals and Intellectual PropertyAugust 28, 2020 Please join us for an Executive Education Program on Health, Pharmaceuticals and Intellectual Property, co-sponsored…Doris Estelle LongSrividhya Ragavan Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long COVID-19Trade PolicyTRIPS Coronavirus & Restoring Trade: Access to Healthcare as the SolutionMay 18, 2020 The coronavirus pandemic is a global emergency that pertains to health but threatens to destroy…Srividhya Ragavan Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
TAMU Executive Education Program on Health, Pharmaceuticals and Intellectual PropertyAugust 28, 2020 Please join us for an Executive Education Program on Health, Pharmaceuticals and Intellectual Property, co-sponsored…Doris Estelle LongSrividhya Ragavan Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long COVID-19Trade PolicyTRIPS Coronavirus & Restoring Trade: Access to Healthcare as the SolutionMay 18, 2020 The coronavirus pandemic is a global emergency that pertains to health but threatens to destroy…Srividhya Ragavan Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long COVID-19Trade PolicyTRIPS Coronavirus & Restoring Trade: Access to Healthcare as the SolutionMay 18, 2020 The coronavirus pandemic is a global emergency that pertains to health but threatens to destroy…Srividhya Ragavan Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long COVID-19Trade PolicyTRIPS Coronavirus & Restoring Trade: Access to Healthcare as the SolutionMay 18, 2020 The coronavirus pandemic is a global emergency that pertains to health but threatens to destroy…Srividhya Ragavan Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long COVID-19Trade PolicyTRIPS Coronavirus & Restoring Trade: Access to Healthcare as the SolutionMay 18, 2020 The coronavirus pandemic is a global emergency that pertains to health but threatens to destroy…Srividhya Ragavan Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long COVID-19Trade PolicyTRIPS Coronavirus & Restoring Trade: Access to Healthcare as the SolutionMay 18, 2020 The coronavirus pandemic is a global emergency that pertains to health but threatens to destroy…Srividhya Ragavan Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
COVID-19Trade PolicyTRIPS Coronavirus & Restoring Trade: Access to Healthcare as the SolutionMay 18, 2020 The coronavirus pandemic is a global emergency that pertains to health but threatens to destroy…Srividhya Ragavan